Lin28A and Lin28B are aberrantly expressed in a plethora of tissue malignancies, and activation of either Lin28A or Lin28B is responsible for the global post-transcriptional downregulation of let-7 miRNAs in many cancers, which is associated with advanced tumor stages and poor patient outcomes [55]. The gene discussed is LIN28A; the disease is neoplasm.